The authors attributed the tumor-promoting effect to the ketone body AcAc, which was increased by the KD and enhanced the binding of mutant BRAF (but not wild-type BRAF) to MEK1 to promote MEK-ERK signaling and tumor growth [4]. The gene discussed is BRAF; the disease is neoplasm.